Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs

Adalimumab is the only biological drug approved to date for the treatment of moderate and/or severe hidradenitis suppurativa. Adverse events reported during therapy include paradoxical psoriasiform reactions. No guidelines are currently available for the management of this clinical condition. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Burzi, Lorenza, Repetto, Federica, Ribero, Simone, Mastorino, Luca, Quaglino, Pietro, Dapavo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078212/
https://www.ncbi.nlm.nih.gov/pubmed/36175129
http://dx.doi.org/10.1111/dth.15866
_version_ 1785020469352595456
author Burzi, Lorenza
Repetto, Federica
Ribero, Simone
Mastorino, Luca
Quaglino, Pietro
Dapavo, Paolo
author_facet Burzi, Lorenza
Repetto, Federica
Ribero, Simone
Mastorino, Luca
Quaglino, Pietro
Dapavo, Paolo
author_sort Burzi, Lorenza
collection PubMed
description Adalimumab is the only biological drug approved to date for the treatment of moderate and/or severe hidradenitis suppurativa. Adverse events reported during therapy include paradoxical psoriasiform reactions. No guidelines are currently available for the management of this clinical condition. The aim of this paper is to describe the incidence and clinical features of paradoxical psoriasiform eruptions occurring during treatment with adalimumab in patients with hidradenitis suppurativa and to report real‐life experience in management and the possible role of other biologic agents for the treatment of both conditions.
format Online
Article
Text
id pubmed-10078212
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100782122023-04-07 Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs Burzi, Lorenza Repetto, Federica Ribero, Simone Mastorino, Luca Quaglino, Pietro Dapavo, Paolo Dermatol Ther Short Reports Adalimumab is the only biological drug approved to date for the treatment of moderate and/or severe hidradenitis suppurativa. Adverse events reported during therapy include paradoxical psoriasiform reactions. No guidelines are currently available for the management of this clinical condition. The aim of this paper is to describe the incidence and clinical features of paradoxical psoriasiform eruptions occurring during treatment with adalimumab in patients with hidradenitis suppurativa and to report real‐life experience in management and the possible role of other biologic agents for the treatment of both conditions. John Wiley & Sons, Inc. 2022-10-13 2022-12 /pmc/articles/PMC10078212/ /pubmed/36175129 http://dx.doi.org/10.1111/dth.15866 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Short Reports
Burzi, Lorenza
Repetto, Federica
Ribero, Simone
Mastorino, Luca
Quaglino, Pietro
Dapavo, Paolo
Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs
title Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs
title_full Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs
title_fullStr Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs
title_full_unstemmed Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs
title_short Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs
title_sort paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: real‐life experience and therapeutic response to other biological drugs
topic Short Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078212/
https://www.ncbi.nlm.nih.gov/pubmed/36175129
http://dx.doi.org/10.1111/dth.15866
work_keys_str_mv AT burzilorenza paradoxicalpsoriasiformreactionsduringtreatmentwithadalimumabforhidradenitissuppurativareallifeexperienceandtherapeuticresponsetootherbiologicaldrugs
AT repettofederica paradoxicalpsoriasiformreactionsduringtreatmentwithadalimumabforhidradenitissuppurativareallifeexperienceandtherapeuticresponsetootherbiologicaldrugs
AT riberosimone paradoxicalpsoriasiformreactionsduringtreatmentwithadalimumabforhidradenitissuppurativareallifeexperienceandtherapeuticresponsetootherbiologicaldrugs
AT mastorinoluca paradoxicalpsoriasiformreactionsduringtreatmentwithadalimumabforhidradenitissuppurativareallifeexperienceandtherapeuticresponsetootherbiologicaldrugs
AT quaglinopietro paradoxicalpsoriasiformreactionsduringtreatmentwithadalimumabforhidradenitissuppurativareallifeexperienceandtherapeuticresponsetootherbiologicaldrugs
AT dapavopaolo paradoxicalpsoriasiformreactionsduringtreatmentwithadalimumabforhidradenitissuppurativareallifeexperienceandtherapeuticresponsetootherbiologicaldrugs

Ejemplares similares